Journalism of Courage
Osteiod Osteoma represents about 10 to 12 per cent of all benign bone tumour cases
Osteiod Osteoma accounts for 10 to 12 per cent of all benign bone tumours. Characterised by less than 1.5 cm in diameter,the benign bone tumour,most frequently occurs in young men (the male-female ratio is 3:1). It may occur in any bone of the body,most frequently around the knee but is often seen in the vertebrae,in the long bones,and less commonly,in other craniofacial bones.
The types of treatment for Osteiod Osteoma vary based on the health of the individual with the tumour. These can be treated with non-steroidal,anti-inflammatory,surgical or percutaneous radiofrequency ablation (the use of electrodes to generate heat and destroy abnormal tissue through the skin). Rama’s time was restricted and she wanted to get back home at the earliest,hence Percutaneous Radiofrequency Ablation (RFA) was the preferred treatment option in her case.
“This is a minimally invasive procedure in which radio frequencies are passed beneath the skin through a needle to kill the tumour cells by heating them to a high temperature,” explains Munde,who performed this technique under CT scan guidance. RFA is preferred because it can be done on day-care basis,is minimally invasive,has a very short recovery time (unlike open surgery,which needs a few weeks’ rest),has 100 per cent technical success rate,is a curative treatment and does not weaken the bone as much a surgery does,” he adds further.
The procedure went on for one hour and Rama was discharged within 12. At the time of discharge,she was completely relieved from the pain due to the tumour,says Munde.
